Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatima Teixeira-Clerc

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Hepatology (Baltimore, Md.)|June 4, 2013
Reply: To PMID 23728734Fatima Teixeira-Clerc, Sophie Lotersztajn
The Journal of Biological Chemistry|May 15, 2002
How do short neurotoxins bind to a muscular-type nicotinic acetylcholine receptor?Fatima Teixeira-Clerc, André Ménez, Pascal Kessler
Journal of Hepatology|April 10, 2013
Cannabinoid signaling and liver therapeuticsAriane Mallat, Fatima Teixeira-Clerc, Sophie Lotersztajn
Bioconjugate Chemistry|May 22, 2003
A cysteine-linkable, short cleavable photoprobe with dual functionality to explore protein-protein interfacesFatima Teixeira-Clerc, Sophie Michalet, André Ménez, et al.
Expert Opinion on Therapeutic Targets|February 15, 2007
Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseasesAriane Mallat, Fatima Teixeira-Clerc, Vanessa Deveaux, et al.
Annual Review of Pharmacology and Toxicology|October 9, 2004
Hepatic fibrosis: molecular mechanisms and drug targetsSophie Lotersztajn, Boris Julien, Fatima Teixeira-Clerc, et al.
Journal of Hepatology|September 1, 2004
Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblastsLiying Li, Boris Julien, Pascale Grenard, et al.
Biomed Research International|September 26, 2014
Autophagy: a multifaceted partner in liver fibrosisAriane Mallat, Jasper Lodder, Fatima Teixeira-Clerc, et al.
Gastroenterologie Clinique Et Biologique|March 31, 2007
[Endocannabinoids: therapeutic perspectives in chronic liver diseases]Sophie Lotersztajn, Fatima Teixeira-Clerc, Christophe Hezode, et al.
Scientific Reports|June 28, 2016
The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent PathwayTimothé Denaës, Jasper Lodder, Marie-Noële Chobert, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|June 4, 2013
Reply: To PMID 23728734Fatima Teixeira-Clerc, Sophie Lotersztajn
The Journal of Biological Chemistry|May 15, 2002
How do short neurotoxins bind to a muscular-type nicotinic acetylcholine receptor?Fatima Teixeira-Clerc, André Ménez, Pascal Kessler
Journal of Hepatology|April 10, 2013
Cannabinoid signaling and liver therapeuticsAriane Mallat, Fatima Teixeira-Clerc, Sophie Lotersztajn
Bioconjugate Chemistry|May 22, 2003
A cysteine-linkable, short cleavable photoprobe with dual functionality to explore protein-protein interfacesFatima Teixeira-Clerc, Sophie Michalet, André Ménez, et al.
Expert Opinion on Therapeutic Targets|February 15, 2007
Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseasesAriane Mallat, Fatima Teixeira-Clerc, Vanessa Deveaux, et al.
Annual Review of Pharmacology and Toxicology|October 9, 2004
Hepatic fibrosis: molecular mechanisms and drug targetsSophie Lotersztajn, Boris Julien, Fatima Teixeira-Clerc, et al.
Journal of Hepatology|September 1, 2004
Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblastsLiying Li, Boris Julien, Pascale Grenard, et al.
Biomed Research International|September 26, 2014
Autophagy: a multifaceted partner in liver fibrosisAriane Mallat, Jasper Lodder, Fatima Teixeira-Clerc, et al.
Gastroenterologie Clinique Et Biologique|March 31, 2007
[Endocannabinoids: therapeutic perspectives in chronic liver diseases]Sophie Lotersztajn, Fatima Teixeira-Clerc, Christophe Hezode, et al.
Scientific Reports|June 28, 2016
The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent PathwayTimothé Denaës, Jasper Lodder, Marie-Noële Chobert, et al.
Pageof 3